Genetic analysis of 209 MS patients revealed no influence of the polymorphism on the disease course, however, hypomethylation of the BDNF gene in the exonic CpG-site affected by the polymorphism was associated with a higher burden of disability. This evidence concerns the gene BDNF and myeloid sarcoma.